SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-17-006367
Filing Date
2017-10-27
Accepted
2017-10-27 16:59:09
Documents
68
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q f10q_102717p.htm 10-Q 321954
2 EXHIBIT 10.1 exh_101.htm EX-10.1 1279184
3 EXHIBIT 10.2 exh_102.htm EX-10.2 154313
4 EXHIBIT 31.1 exh_311.htm EX-31.1 8654
5 EXHIBIT 31.2 exh_312.htm EX-31.2 8714
6 EXHIBIT 32.1 exh_321.htm EX-32.1 3373
  Complete submission text file 0001171843-17-006367.txt   4337736

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE anik-20170930.xml EX-101.INS 479222
8 XBRL SCHEMA FILE anik-20170930.xsd EX-101.SCH 46294
9 XBRL CALCULATION FILE anik-20170930_cal.xml EX-101.CAL 34702
10 XBRL DEFINITION FILE anik-20170930_def.xml EX-101.DEF 310568
11 XBRL LABEL FILE anik-20170930_lab.xml EX-101.LAB 241882
12 XBRL PRESENTATION FILE anik-20170930_pre.xml EX-101.PRE 325923
Mailing Address 32 WIGGINS AVENUE BEDFORD MA 01730
Business Address 32 WIGGINS AVENUE BEDFORD MA 01730 (781) 457-9000
Anika Therapeutics, Inc. (Filer) CIK: 0000898437 (see all company filings)

IRS No.: 043145961 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14027 | Film No.: 171160045
SIC: 3841 Surgical & Medical Instruments & Apparatus
Industrial Applications and Services